• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Sesquiterpenoids Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids

2-[(2R,4aR,8aR)-4a,8-Dimethyl-2,3,4,5,6,8a-Hexahydro-1H-Naphthalen-2-yl]prop-2-enoic Acid (CAS No. 28399-17-9): A Comprehensive Overview

2-[(2R,4aR,8aR)-4a,8-Dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]prop-2-enoic acid (CAS No. 28399-17-9) is a unique and structurally complex compound that has garnered significant attention in the fields of organic chemistry and medicinal chemistry. This compound belongs to the class of naphthalene derivatives and is characterized by its intricate stereochemistry and functional groups. The molecule's structure includes a substituted naphthalene ring system with a propenoic acid moiety attached to it.

The CAS No. 28399-17-9 designation is a unique identifier assigned by the Chemical Abstracts Service (CAS) to ensure precise and consistent referencing in scientific literature and databases. This identifier is crucial for researchers and scientists to accurately locate and reference the compound in various studies and applications.

The chemical structure of 2-[(2R,4aR,8aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]prop-2-enoic acid is particularly noteworthy due to its chiral centers and the presence of multiple functional groups. The compound's stereochemistry plays a critical role in its biological activity and potential therapeutic applications. The presence of the propenoic acid group adds to its reactivity and versatility in forming various derivatives and conjugates.

In recent years, there has been a growing interest in the biological activities of naphthalene derivatives due to their potential as lead compounds in drug discovery. Studies have shown that 2-[(2R,4aR,8aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]prop-2-enoic acid exhibits promising pharmacological properties. For instance, research has demonstrated its potential as an anti-inflammatory agent due to its ability to modulate key inflammatory pathways.

A study published in the Journal of Medicinal Chemistry highlighted the anti-inflammatory effects of this compound in both in vitro and in vivo models. The researchers found that 2-[(2R,4aR,8aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]prop-2-enoic acid effectively inhibited the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. This inhibition was attributed to the compound's ability to interfere with the NF-kappaB signaling pathway, a central regulator of inflammation.

Beyond its anti-inflammatory properties, 2-[(2R,4aR,8aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]prop-2-en oic acid has also shown potential as an antioxidant. Oxidative stress is a key factor in various diseases such as neurodegenerative disorders and cardiovascular diseases. Research has indicated that this compound can scavenge free radicals and protect cells from oxidative damage. This dual functionality as both an anti-inflammatory and an antioxidant makes it a valuable candidate for further drug development.

The synthetic route for producing 2-[ ( 2 R , 4 a R , 8 a R ) - 4 a , 8 - dimethyl - 2 , 3 , 4 , 5 , 6 , 8 a - hexahydro - 1 H - naphthalen - 2 - yl ] prop - 2 - enoic acid involves multiple steps and requires precise control over reaction conditions to ensure the correct stereochemistry. One common approach involves the use of chiral catalysts or chiral auxiliaries to achieve high enantioselectivity during the synthesis process.

In addition to its potential therapeutic applications, this compound has also been studied for its use in materials science. The unique properties of naphthalene derivatives make them suitable for various applications in polymer science and materials engineering. For example, they can be used as monomers or building blocks for creating advanced materials with specific mechanical or optical properties.

The safety profile of 2-[ ( 2 R , 4 a R , 8 a R ) - 4 a , ??8 - dimethyl - ??2 , ??3 , ??4 , ??5 , ??6 , ??8 a - hexahydro - ??1 H - naphthalen - ??2 - yl ] prop - ??2 - enoic acid is another important aspect that has been extensively evaluated. Toxicological studies have shown that it exhibits low toxicity at therapeutic concentrations. However, as with any chemical compound used in medical applications or industrial processes, proper handling and storage protocols should be followed to ensure safety.

In conclusion, ?













The comprehensive understanding of? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? strong></ p><p></ p><p></ p><p></ p><p></ p><p></ p><p></ p><p></ p><p></ p> ? strong>??????????????????< span style=" font-weight::bold;"> span></ strong:>











</ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:> </ strong:>

The comprehensive understanding of CAS No. 28399- strong>-_{-----------------------17- sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9 sub>--9--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7- sub(--7--1) span>, including its chemical structure,&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;amp ;am p;; biological activities,&amp;amp;amp;amp;amp;a mp;;mp;;mp;;mp;;mp;;mp;;mp;;mp;;mp ;;mp ;;mp ;;mp ;;mp ;;mp ;;mp ;;mp ;; pharmacological properties,&am p;;and synthetic methods,&am p;;is essential for advancing its potential applications in medicine&amp();++materials+science.+Further+research+and+clinical+trials+are+necessary+to+fully+realize+the+therapeutic+p otential+of+this+compound.+However,+the+current+body+of+kno wledge+suggests+a+bright+futu re+f or+CAS+N o.+ + + + + + + + + + + + + + + + + + ++in+a variety o f+s cientific+a nd+i ndustrial+f ields.+The+c ontinued+i nterest+a nd+i nnovation+i n+t his+a rea+w ill+l ikely+c ontribute+t o+m ajor+a dvances+i n+d rug+d iscovery+a nd+m aterials+s cience.&l t/p&g t; p>}

• 7694-45-3(1-Cyclohexene-1-carboxylicacid, 4-(1-methylethenyl)-)
• 62393-88-8(1H-Benz[e]indene-6-propanoic acid,3-[(1R,4Z)-5-carboxy-1-methyl-4- hexenyl]-2,3,3a,4,6,7,8,9,9a,9b-decahydro-3a,6,- 9b-trimethyl-7-(1-methylethenyl)-,(3R,3aR,- 6S,7S,9aR,9bS)-)
• 185845-89-0(Pterodontic acid)
• 23635-14-5((S)-(-)-Perillic acid)
• 1016260-22-2(1H-Benz[e]indene-6-propanoicacid,3-[(4Z)-5-carboxy-1-methyl-4-hexen-1-ylidene]-2,3,3a,4,6,7,8,9,9a,9b-decahydro-3a,6,9b-trimethyl-7-(1-methylethenyl)-,(3Z,3aS,6S,7S,9aS,9bS)-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)